SCHEMBL30298002

SCHEMBL30298002

CCOC(=O)c1cn(CC2CCC2)c2nc(Cl)c(Cl)cc2c1=O

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ ATM Q13315 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ BAZ2B Q9UIF8 1/20 0.39
▸ BAZ2A Q9UIF9 1/20 0.39
▸ MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10473152 0.81 ADRB2 (0.44) POLBALDH1A1ATMTDP1HPGD
SCHEMBL30297993 0.80 ELANE (0.39) POLBALDH1A1ATMTDP1HPGD
SCHEMBL7582040 0.75 ADRB2 (0.44) POLBALDH1A1ATMTDP1HPGD
SCHEMBL11289462 0.75 POLB (0.53) POLBALDH1A1TDP1HPGDKMT2A
SCHEMBL3977245 0.75 ALDH1A1 (0.53) POLBALDH1A1TDP1HPGDKMT2A
SCHEMBL30181075 0.74 NPC1 (0.44) POLBALDH1A1TDP1KMT2AMAPT
SCHEMBL31310726 0.73 LMNA (0.54) POLBALDH1A1ATMTDP1HPGD
SCHEMBL31310725 0.73 LMNA (0.72) POLBALDH1A1TDP1HPGDKMT2A
SCHEMBL30954831 0.73 CSF1R (0.41) POLBALDH1A1HPGDKMT2AMAPT
SCHEMBL30297987 0.73 CSF1R (0.41) POLBALDH1A1HPGDKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399206-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES Redona Therapeutics, Inc. (US) 2024-07-17 — — EP disclosed
CN-118201914-A 4-Oxo-1, 4-dihydroquinoline-3-carboxylic acid derivatives as PAPD5 and/or PAPD7 inhibitors 雷多纳治疗公司 2024-06-14 — — CN disclosed
WO-2023039089-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES TWENTYEIGHT-SEVEN, INC. (US) 2023-03-16 — — WO disclosed
Send feedback